NEW YORK — Glucose tracking is the future, Dexcom executives gushed at a glitzy launch event for their new, over-the-counter continuous glucose monitor on Wednesday evening. Surrounded by ...

In particular, GPCRs play essential roles in the central nervous system, including neurotransmission and neuronal metabolism, as well as in energy homeostasis, including modulation of insulin ...

Most people with diabetes should test their blood sugar (or blood glucose) levels regularly. Knowing the results lets you adjust your strategy for keeping the disease in check. Research shows that ...

Most protein-targeting drugs are prizes that drug developers have unearthed from G protein–coupled receptor (GPCR) interactomes. So, when GPCR-targeting drugs become harder to find, one might ...

Explore how peptide drugs are changing the hundred-billion-level weight loss market, and how this landscape is changing as ...

We also develop phototropin and cryptochrome-based optogenetic tools for regulating G protein signaling independent of GPCRs. These engineered tools allow the acquisition ... to hijack signaling ...

San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing ...

After getting the green light from the FDA back in March, Dexcom today launched its first over-the-counter wearable continuous glucose biosensor, Stelo, in the U.S. market. The device is now ...

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. A mere six months ago Verily ...

Glucose is available from most supermarkets’ baking sections. Glucose is used commercially in instant energy drinks, and for increasing the sugar content of wine, beer, confectionery, ice creams ...

In this article, we are going to take a look at where Structure Therapeutics Inc. (NASDAQ:GPCR) stands against the other mid-cap healthcare stocks. According to projections by ReportLinker ...

NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end-of-month settlement dates. It is then ...